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Pssociation of Myocardial
schemia With Mortality and Implantable
ardioverter-Defibrillator Therapy in Patients With
oronary Artery Disease at Risk of Arrhythmic Death
bdou Elhendy, MD, PHD, FACC, Scott Chapman, MD, Thomas R. Porter, MD, FACC,
ohn Windle, MD, FACC
maha, Nebraska
OBJECTIVES We sought to assess the relation between myocardial ischemia during stress echocardiography
and major events in patients with implantable cardioverter-defibrillator (ICD).
BACKGROUND The association of myocardial ischemia with subsequent ICD therapy and mortality is unknown.
METHODS We studied 90 patients (age 65 13 years, 27 women) with history of coronary heart disease who
received ICD for primary (53 patients) or secondary (37 patients) prevention of sudden cardiac
death. Sixty-five (72%) patients had a previous coronary artery bypass surgery. Patients underwent
exercise treadmill or dobutamine stress echocardiography. Ischemia was defined as new or
worsening wall motion abnormalities. End points were death and appropriate ICD therapy.
RESULTS Mean ejection fraction was 34 12%. During a mean follow-up of 2.8 1.5 years, 5 patients
died and 19 patients had ICD therapy. Ischemia was detected in 20 of 24 patients with
subsequent events and in 24 of 66 patients without (83% vs. 36%, p  0.001). Events
occurred in 17 of the 32 patients (53%) with both ischemia and inducible ventricular
tachycardia (VT) on electrophysiologic (EP) studies. None of the 16 patients without
ischemia or inducible VT on EP studies had events. In a Cox multivariate analysis model,
independent predictors of events were a history of spontaneous sustained VT (hazard ratio
[HR] 1.9, 95% confidence interval [CI] 1.3 to 3.8), inducible VT on EP studies (HR 1.7,
95% CI 1.2 to 4.5), and ischemia (HR 2.1, 95% CI 1.2 to 3.5).
CONCLUSIONS Ischemia during stress echocardiography is an independent predictor of death and ICD therapy
in patients with coronary heart disease at high risk of arrhythmic death. Patients without inducible
ischemia or VT on a previous EP study have a very low risk of events. A combination of ischemia
and a positive EP study is associated with a very high risk of events. (J Am Coll Cardiol 2005;
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.04.06546:1721–6) © 2005 by the American College of Cardiology Foundation
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deveral randomized clinical trials have demonstrated the
sefulness of the implantable cardioverter-defibrillator
ICD) for the prevention of sudden cardiac death caused by
entricular tachyarrhythmias (1–5). Recent advances in ICD
echnology have resulted in an increase in the number of
See page 1727
CD recipients and expansion of ICD indications (6).
he occurrence of sustained ventricular arrhythmias with
ubsequent ICD therapy in these patients has major
linical implications (7–12). Implantable cardioverter-
efibrillator shocks often cause major discomfort and
sychological distress and might lead to more frequent
ospital visits and necessitate addition of antiarrhythmic
rugs with potential toxicities (7,8). Some studies have
eported an association of multiple ICD therapy with
ncreased risk of death (7). Identification of a precipitat-
ng factor for sustained ventricular arrhythmias might
From the Department of Internal Medicine, Section of Cardiology, University of
ebraska Medical Center, Omaha, Nebraska.e
Manuscript received February 15, 2005; revised manuscript received March 27,
005, accepted April 13, 2005.otentially lead to reducing the incidence and frequency
f ICD therapy.
Coronary artery disease (CAD) is the underlying mech-
nism of left ventricular dysfunction and ventricular ar-
hythmias in the majority of ICD recipients (5). Ameliora-
ion of myocardial ischemia with revascularization
rocedures in the appropriate patients is attempted before or
n conjunction with ICD implantation in patients with
schemic heart disease and sudden cardiac death or with
igh risk of arrhythmic death; however, incomplete revas-
ularization, progression of native CAD, restenosis after
ercutaneous interventions, and graft occlusion might com-
romise myocardial perfusion in patients with ICD and
ontribute to further myocardial damage, arrhythmias, or
orsening of heart failure symptoms.
Stress echocardiography is an increasingly used tool for
unctional evaluation of patients with known or suspected
AD (13–17). Myocardial ischemia assessed by this tech-
ique was shown to predict adverse outcome (13–17),
lthough the association of myocardial ischemia with mor-
ality and ICD therapy in patients at high risk of arrhythmic
eath has not been previously studied. The aim of this study
as to find whether myocardial ischemia on stress echocar-
iography can predict mortality and major arrhythmic
vents in patients with an ICD.
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atient population. The study population consisted of 90
onsecutive patients with history of CAD, treated with an
CD for secondary or primary prevention of sudden cardiac
eath, who underwent dobutamine or exercise stress echo-
ardiography for evaluation of myocardial ischemia between
eptember 1997 and December 2002 at the University of
ebraska Medical Center, Omaha, Nebraska. A history of
AD was defined as previous myocardial infarction, myo-
ardial revascularization, and/or 50% luminal diameter
tenosis of 1 major epicardial coronary arteries in a
revious coronary angiogram. Exclusion criteria were unsta-
le chest pain and congestive heart failure functional class
V unresponsive to medical therapy. All patients gave an
nformed consent to undergo the stress echocardiography
est. The Institute Review Board of the University of
ebraska Medical Center approved the protocol of the
tudy.
tress echocardiography protocols. Beta-blockers were
iscontinued at least 24 h before the stress echocardiogram.
ther medications were not discontinued. Serum electro-
ytes were not routinely measured. Some particular precau-
ions are required in our laboratory when stressing patients
ith ICD. All the stress studies in these patients are
erformed in the presence of a cardiologist and a nurse
ractitioner who is experienced in the management of an
CD device. The ICD is made in an inactive mode before
he stress test and is activated after the recovery (18). In
nticipation of any serious tachyarrhythmias, the patients
hould be continuously monitored and supervised. The ICD
hould be activated immediately to deliver a shock if the
atient develops ventricular fibrillation or had ventricular
achycardia (VT) that is sustained and not responding to
est termination, metoprolol, or lidocaine.
Symptom-limited exercise treadmill stress test was per-
ormed in 15 patients (17%) with the standard Bruce
rotocol. End points were significant symptoms reported by
he patient (angina, fatigue, dizziness, dyspnea), 2 mV
ownsloping ST-segment depression measured 80 ms from
he J point compared with baseline, symptomatic decrease in
ystolic blood pressure, and symptomatic or sustained ven-
ricular or supraventricular tachycardia. Dobutamine stress
est was performed in 75 patients (18). Dobutamine was
nfused at a starting dose of 5 g/kg/min for 3 min,
ollowed by 10 g/kg/min for 3 min (low-dose stage). The
Abbreviations and Acronyms
CAD  coronary artery disease
CI  confidence interval
EP  electrophysiology/electrophysiologic
HR  hazard ratio
ICD  implantable cardioverter-defibrillator
VT  ventricular tachycardiaobutamine dose was increased by 10 g/kg/min every 3 min up to a maximum dose of 50 g/kg/min. Atropine (up
o 2 mg) was administered intravenously if 85% of maximal
redicted heart rate (220  age) was not achieved. End
oints of dobutamine stress test were achievement of target
eart rate, maximal dose of dobutamine and atropine,
xtensive new wall motion abnormalities, 2 mm
ownsloping ST-segment depression measured 80 ms from
he J point compared with baseline, hypertension (blood
ressure 240/120 mm Hg), symptomatic decrease in
ystolic blood pressure, symptomatic or sustained ventricular
r supraventricular tachycardia, or any intolerable adverse
ffect considered to be the result of dobutamine. Metoprolol
1 to 5 mg) was used intravenously to reverse the side effects
f dobutamine if these did not revert quickly after termina-
ion of dobutamine infusion. The ICD was reactivated 6
in after the stress test.
chocardiographic imaging and interpretation. Images
ere acquired at rest and immediately after exercise stress.
n patients who underwent dobutamine stress, images were
cquired at rest, low dose, peak stress, and recovery. Images
ere recorded on videotapes, and the baseline and stress
mages were recorded in a quad-screen format. For segmen-
al analysis of left ventricular function, a 16-segment model
as used as suggested by the American Society of Echocar-
iography (19). Each segment was scored with a 5-point
cale, with 1  normal, 2  mild hypokinesis, 3  severe
ypokinesis, 4  akinesis, and 5  dyskinesis. Ejection
raction at rest was measured with a previously validated
odification of the method of Quinones et al. or by visual
stimation (20,21). Ischemia was defined as new or wors-
ned wall motion abnormalities during stress indicated by
n increase of wall motion score 1 grade in 1 segment.
iphasic response to dobutamine in a dyssynergic segment
as considered as an ischemic response. Akinesis becoming
yskinesis was not considered an ischemic response (22).
ollow-up. Follow-up was obtained by scheduled clinic
isit to the electrophysiology (EP) clinic of our institute.
atients underwent a regular ICD interrogation at an
verage interval of six months or shorter if clinically re-
uired. Hospital records were also reviewed. Patients who
nderwent myocardial revascularization were censored at
he time of revascularization. The end points considered
ere death and appropriate ICD therapy defined as an
ntitachycardia pacing therapy or shock for arrhythmia
etermined to be either VT or ventricular fibrillation. Death
as considered cardiac if it was caused by acute myocardial
nfarction, significant cardiac arrhythmias, or refractory
eart failure. Sudden unexpected death occurring without
nother explanation was included as cardiac death. Verifi-
ation of events was performed by an investigator who did
ot participate in interpretation of the echocardiograms.
tatistical analysis. Continuous data are presented as
ean values  SD. The chi-square test was used to
ompare differences between proportions. The Student t
est was used for analysis of continuous data. Cox regression
odels were used to identify predictors of follow-up events.
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November 1, 2005:1721–6 Predictors of ICD Shocksariables included in the multivariate model were the
ariables that were significant (p  0.05) in the univariate
nalysis. The probability of survival with freedom from ICD
herapy was calculated with the Kaplan-Meier method.
vent-free survival curves were compared in patients with
nd without ischemia by using the log-rank test. Differences
ere considered significant if the null hypothesis could be
ejected at the 0.05 probability level.
ESULTS
linical data. Clinical data are presented in Table 1.
ndications for stress testing were evaluation of chest pain in
0 patients, functional assessment after revascularization in
6 patients, and detection of a reversible cause of heart
ailure in 14 patients. The EP studies were positive for
nducible sustained monomorphic VT in 62 (69%) patients.
he ICD was placed in the remaining patients: those
ithout inducible VT because of history of sudden cardiac
eath (16 patients), recurrent symptomatic VT patients who
ailed to tolerate or to respond to antiarrhythmic therapy (4
atients), and those with severe left ventricular dysfunction
ith spontaneous non-sustained VT (8 patients). Fourteen
16%) patients had atrial fibrillation as a baseline rhythm.
he stress test was performed 3  2.1 years after ICD
mplantation. Among patients with previous myocardial
evascularization, the stress test was performed at a mean of
.5  2.8 years since the last revascularization procedure.
tress test and echocardiographic data. There was a
ignificant increase of heart rate (71  14 vs. 137  16
eats/min) from rest to peak stress. The target heart rate
as reached in 81 (90%) patients. Systolic blood pressure
ncreased with exercise (144  26 vs. 165  32 mm Hg),
ut not with dobutamine (142  29 vs. 140  35 mm Hg).
here was no incidence of death, myocardial infarction,
entricular fibrillation, or sustained VT during or shortly
able 1. Clinical Features of the Study Patients
Clinical Features n  90
ge (yrs) 65  13
omen 27 (30%)
revious myocardial infarction 78 (87%)
revious coronary artery bypass grafting 65 (72%)
revious percutaneous intervention 30 (33%)
iabetes mellitus 20 (22%)
ypertension 67 (74%)
igarette smoking 5 (6%)
ypercholesterolemia 57 (63%)
istory of cardiac arrest 37 (41%)
istory of syncope 14 (16%)
istory of sustained ventricular tachycardia 45 (50%)
ngina 20 (22%)
typical chest pain 30 (33%)
eart failure 33 (37%)
edications
Beta-blockers 60 (67%)
Calcium channel blockers 28 (31%)
Angiotensin-converting enzyme inhibitors 63 (70%)sAntiarrhythmic medications 38 (42%)fter the stress test. Non-sustained VT occurred in six (7%)
atients and supraventricular tachycardia occurred in two
2%) patients. One patient developed transient atrial fibril-
ation. Arrhythmias were terminated spontaneously, by
topping dobutamine infusion or by administration of
etoprolol. Among the six patients with induced VT, two
ad inducible ischemia. Four of the six patients with stress
nduced VT had electrolyte levels measured within one
eek. None had a serum potassium level 3.6 mEq.
The mean dobutamine dose was 36  9 g/kg/min.
tropine was used in 35 (39%) patients; ST-segment
epression occurred in 17 (21%) patients and angina oc-
urred in 14 (17%) patients. Mean ejection fraction was 34
12%. Ischemia was detected in 44 (49%) patients.
ollow-up. During a mean follow-up of 2.8  1.5 years
range, 6 to 62 months), 5 patients died and 19 patients had
ppropriate ICD therapy (shock in 14 patients and anti-
achycardia pacing in 5 patients). Thirteen (14%) patients
nderwent revascularization during follow-up and were
ensored at the time of revascularization (10 of these
atients had inducible ischemia). Among the 34 patients
ith ischemia who did not undergo revascularization, 10
atients preferred medical treatment, 3 patients had mildly
bstructive CAD, 9 patients had angiographic stenosis of
ow feasibility for intervention, 5 patients had renal dysfunc-
ion and were considered at very high risk of contrast
ephropathy requiring dialysis, and 7 patients were consid-
red to have mild ischemia and were advised to continue
edical treatment.
All of the five patients who died during follow-up had
nducible ischemia. Four of these patients had both peri-
nfarction and remote ischemia, and one had only remote
schemia. Death was classified as cardiac in three patients.
ther causes of death were stroke in one patient and
omplications of peripheral vascular disease in one patient.
linical and echocardiographic data of patients with and
ithout events (death and ICD therapy) are presented in
able 2. Patients who had events more often had a history
f spontaneous sustained VT, inducible VT at EP studies,
nd ischemia on stress echocardiogram.
Thirty-two patients had both ischemia and positive EP
tudy; events occurred in 17 (53%) of them. Thirty patients
ad positive EP study without ischemia; events occurred in
(13%) of them. Twelve patients had ischemia and negative
P study; events occurred in 3 (25%) of them. No events
ccurred among the 16 patients who had neither ischemia
or positive EP study.
redictors of events. Significant variables from Table 2
ere considered in the Cox multivariate analysis model. The
ndependent predictors of events in the Cox model were a
istory of spontaneous sustained VT (hazard ratio [HR]
.9, 95% confidence interval [CI] 1.3 to 3.8, p  0.01),
nducible VT on EP studies (HR 1.7, 95% CI 1.2 to 4.5, p
0.01), and myocardial ischemia (HR 2.1, 95% CI 1.2 to
.5, p  0.01). Age and resting ejection fraction were not
ignificant in univariate analysis or after being forced in the
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n patients with and without ischemia are presented in
igure 1.
ISCUSSION
mplantable cardioverter defibrillator therapy is a leading
ause of hospital admission in ICD recipients (7,8). In
ddition to quality of life issues, multiple shocks were shown
o act as potent predictors of survival independent of several
ther risk factors, particularly ejection fraction (7). There-
ore, identification of reversible causes of sustained ventric-
lar arrhythmias in these patients might have important
linical implications.
In this study, we assessed the relation between myocardial
schemia during exercise or dobutamine stress echocardiog-
aphy and the occurrence of death or appropriate ICD
herapy in 90 patients with history of CAD who received an
Table 2. Clinical and Stress Test Data of Patie
Parameters
Age, yrs
Women
Diabetes mellitus
Hypertension
Sudden cardiac death
Spontaneous sustained ventricular tachycardia
Inducible ventricular tachycardia on EP study
Antiarrhythmic therapy
Beta-blockers
Heart failure
Ventricular tachycardia with stress
Stress heart rate
Stress-induced angina
ST-segment depression
Ejection fraction
Ischemia
Peri-infarction
Remote
Both
Number of ischemic segments
Cardiac dimensions
Left ventricular end diastolic diameter
Left ventricular end systolic diameter
Left atrial diameter
EP  electrophysiologic.i
igure 1. Kaplan-Meier event-free survival curves in patients with and
ithout ischemia during stress echocardiography.CD for primary or secondary prevention of sudden cardiac
eath. The majority of patients have received previous
yocardial revascularization. The test was tolerated in
ll patients without serious side effects. During a mean
ollow-up of 2.8 years, 5 patients died and 19 had appro-
riate ICD therapy. A history of sustained VT, inducibility
t EP studies, and myocardial ischemia during stress echo-
ardiography were independently associated with increased
isk of events. Myocardial ischemia remained an indepen-
ent predictor of events, even after forcing age in the
jection fraction in the Cox model.
Our finding of an association of myocardial ischemia with
dverse events in patients with ICD suggests that detection
nd appropriate treatment of myocardial ischemia in these
atients might reduce the incidence or frequency of ICD
herapy and thereby obviate the adverse effects of these
vents on patients’ quality of life, cost of health care, and
eed for additional antiarrhythmic therapy with potential
ide effects. The association of myocardial ischemia with
vents can be explained by the findings of previous studies,
hich have demonstrated that myocardial ischemia acts
s a trigger of serious tachyarrhythmias when superim-
osed on a substrate of fibrotic myocardium (23–25). In
ur study, a combination of inducible VT on EP studies
nd ischemia on the stress echocardiogram was associated
ith a very high risk (53%) of events, whereas the risk was
ery low in the group of patients with neither ischemia nor
nducible VT on EP studies. From these findings, it appears
hat ischemia might be a trigger of arrhythmias, particularly
ith and Without Events
h Events
Patients
Without Events
66 Patients p Value
6  12 65  13 NS
(21%) 22 (33%) NS
(25%) 14 (21%) NS
(75%) 49 (74%) NS
(46%) 26 (39%) NS
(67%) 29 (44%) 0.03
(88%) 41 (62%) 0.02
(42%) 28 (41%) NS
(63%) 45 (68%) NS
(38%) 24 (36%) NS
(13%) 3 (5%) NS
6  16 137  15 NS
(17%) 10 (15%) NS
(21%) 12 (18%) NS
3  12 34  12 NS
(83%) 24 (36%) 0.001
(25%) 5 (8%)
(25%) 6 (9%)
(33%) 13 (20%)
2  1.4 1.4  1.3 0.001
1  2.1 5.9  2 NS
9  1.8 4.8  1.7 NS
4  1.5 5.2  1.5 NSnts W
Wit
24
6
5
6
18
11
16
21
10
15
9
3
13
4
5
3
20
6
6
8
3.
6.
4.
5.n patients with an existing substrate.
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November 1, 2005:1721–6 Predictors of ICD ShocksIt is essential to emphasize that the results of this study
pply to a largely symptomatic population, with the majority
f patients studied at an intermediate follow-up after
evascularization. This is, however, the group of patients in
hom stress testing is clinically required to assess myocar-
ial ischemia.
tress testing in patients with an ICD. There are cur-
ently scarce data regarding the experience with stress
esting in patients with an ICD. We have recently reported
he safety and feasibility of dobutamine stress echocardiog-
aphy for evaluation of myocardial ischemia in patients with
n ICD (18). Gioia et al. (26) studied 101 patients with
istory of ventricular arrhythmias (31 patients after ICD
mplantation) with exercise or vasodilator single photon
mission computed tomographic imaging. The extent of
xed (but not reversible) perfusion abnormalities was pre-
ictive of mortality during a follow-up of 29 months (27).
van der Burg et al. (27) studied 153 survivors of sudden
eath who underwent stress-rest perfusion imaging. Pa-
ients with ischemic/viable myocardium (n  73) were
evascularized if possible. Implantation of ICD was per-
ormed in 112 (72%) patients. During three-year follow-up,
5 cardiac deaths occurred and 42 (29%) patients had
ecurrent ventricular arrhythmias. Patients with events had a
ower ejection fraction, more extensive scar, less ischemic/
iability on perfusion imaging, and less frequently under-
ent revascularization. Multivariate analysis identified ex-
ensive scar and an ejection fraction 30% as the only
redictors of death/recurrent ventricular arrhythmias. The
iscrepancy between their results and ours can be explained
y the fact that stress testing was performed before revas-
ularization in their study with possible amelioration of
schemia. In our study, ischemia was elicited after revascu-
arization.
linical predictors of mortality and ICD therapy. Ri-
aldi et al. (9) studied 155 patients implanted with an ICD.
herapy occurred in 53 (34%) patients. Patients with
herapy had a lower ejection fraction and more often had a
ositive EP study compared with patients without therapy.
atients with dilated cardiomyopathy had a high incidence
f ICD therapy. In these patients EP results were poor
redictors of ICD therapy. Anvari et al. (11) studied 200
atients with ICD during a follow-up of 27  18 months,
he actuarial incidence of appropriate shocks was 18%, 36%,
nd 72% at 1, 3, and 5 years, respectively. Coronary artery
isease was the only significant predictor for shock occur-
ence. One possible explanation of these findings on the
asis of the results of our study is the presence of ischemia
mong patients with CAD.
Pires et al. (28) reported that for many ICD recipients
ho sustained cardiac death, death ensued despite appro-
riate ICD therapy, suggesting acute adverse events as
ommon terminal factors. Because the majority of their
atients had CAD, it is possible that a major ischemic event
as the underlying reason of sudden death in some of these
atients.
1One limitation of the study is the lack of data on diastolic
eft ventricular function. Therefore, it is not known whether
schemia is independently associated with events after ad-
ustment for diastolic function. Although this study con-
rms our previous data on safety of dobutamine stress test in
CD patients (18), further studies including larger number
f patients are required to clarify the safety of stress testing
n these patients.
ummary and conclusions. Myocardial ischemia on stress
chocardiography is associated with an increased risk of
ortality and ICD therapy in patients with CAD at high
isk of arrhythmic death. Therefore, myocardial ischemia
hould be thought of as a reversible cause of arrhythmic
vents in these patients. Patients without inducible ischemia
r VT on a previous EP study have a very low risk of events.
combination of ischemia and a positive EP study is
ssociated with a very high risk of events. Further studies are
equired to assess whether amelioration of ischemia can
educe the incidence of events in ICD recipients.
eprint requests and correspondence: Dr. Abdou Elhendy,
82265 Nebraska Medical Center, Omaha, Nebraska 68198-2265.
-mail: Aelhendy@unmc.edu.
EFERENCES
1. Kuck KH, Cappato R, Siebels J, Rüppel R. Randomized comparison
of antiarrhythmic drug therapy with implantable defibrillators in
patients resuscitated from cardiac arrest: the Cardiac Arrest Study
Hamburg (CASH). Circulation 2000;102:748–54.
2. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an
implanted defibrillator in patients with coronary disease at high risk for
ventricular arrhythmia. Multicenter Automatic Defibrillator Implan-
tation Trial Investigators. N Engl J Med 1996;335:1933–40.
3. Connolly SJ, Gent M, Roberts RS, et al. Canadian Implantable
Defibrillator Study (CIDS): a randomized trial of the implantable
cardioverter defibrillator against amiodarone. Circulation 2000;101:
1297–302.
4. Bardy GH, Lee KL, Mark DB, et al., Sudden Cardiac Death in Heart
Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implant-
able cardioverter-defibrillator for congestive heart failure. N Engl
J Med 2005;352:225–37.
5. Kupersmith J. The past, present, and future of the implantable
cardioverter defibrillator. Am J Med 2002;113:82–4.
6. Swygman C, Wang PJ, Link MS, Homoud MK, Estes NA III.
Advances in implantable cardioverter defibrillators. Curr Opin Cardiol
2002;17:24–8.
7. Villacastin J, Almendral J, Arenal A, et al. Incidence and clinical
significance of multiple consecutive, appropriate, high-energy dis-
charges in patients with implanted cardioverter-defibrillators. Circu-
lation 1996;93:753–62.
8. Korte T, Jung W, Ostermann G, et al. Hospital readmission after
transvenous cardioverter/defibrillator implantation; a single centre
study. Eur Heart J 2000;21:1186–91.
9. Rinaldi CA, Simon RD, Baszko A, et al. Can we predict which
patients with implantable cardioverter defibrillators receive appropriate
shock therapy? A study of 155 patients. Int J Cardiol 2003;88:69–75.
0. Rankovic V, Karha J, Passman R, Kadish AH, Goldberger JJ.
Predictors of appropriate implantable cardioverter-defibrillator therapy
in patients with idiopathic dilated cardiomyopathy. Am J Cardiol
2002;89:1072–6.
1. Anvari A, Gottsauner-Wolf M, Turel Z, et al. Predictors of outcome
in patients with implantable cardioverter defibrillators. Cardiology
1998;90:180–6.2. Dolack GL. Clinical predictors of implantable cardioverter-
defibrillator shocks (results of the CASCADE trial). Cardiac Arrest in
11
1
1
1
1
1
2
2
2
2
2
2
2
2
2
1726 Elhendy et al. JACC Vol. 46, No. 9, 2005
Predictors of ICD Shocks November 1, 2005:1721–6Seattle, Conventional versus Amiodarone Drug Evaluation. Am J
Cardiol 1994;73:237–41.
3. Cheitlin MD, Armstrong WF, Aurigemma GP, et al., ACC/AHA/
ASE 2003 guideline update for the clinical application of echocardi-
ography: summary article. A report of the American College of
Cardiology/American Heart Association Task Force on Practice
Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guide-
lines for the Clinical Application of Echocardiography). J Am Soc
Echocardiogr 2003;16:1091–110.
4. Poldermans D, Fioretti PM, Boersma E, et al. Long-term prognostic
value of dobutamine-atropine stress echocardiography in 1,737 pa-
tients with known or suspected coronary artery disease: a single-center
experience. Circulation 1999;99:757–62.
5. Biagini E, Elhendy A, Bax JJ, et al. Seven-year follow-up after
dobutamine stress echocardiography: impact of gender on prognosis.
J Am Coll Cardiol 2005;45:93–7.
6. Krivokapich J, Child JS, Walter DO, Garfinkel A. Prognostic value of
dobutamine stress echocardiography in predicting cardiac events in
patients with known or suspected coronary artery disease. J Am Coll
Cardiol 1999;33:708–16.
7. Bossone E, Armstrong WF. Exercise echocardiography. Principles,
methods, and clinical use (review). Cardiol Clin 1999;17:447–60.
8. Elhendy A, Windle J, Porter TR. Safety and feasibility of dobutamine
stress echocardiography in patients with implantable cardioverter
defibrillators. Am J Cardiol 2003;92:475–7.
9. Schiller NB, Shah PM, Crawford M, et al. Recommendations for
quantification of the left ventricle by two-dimensional echocardiogra-
phy: American Society of Echocardiography Committee on Standards,
Subcommittee on Quantification of Two-Dimensional Echocardio-
grams. J Am Soc Echocardiogr 1989;2:358–67.
0. Dujardin KS, Enriquez-Sarano M, Rossi A, Bailey KR, Seward JB.
Echocardiographic assessment of left ventricular remodeling: are left
ventricular diameters suitable tools? J Am Coll Cardiol 1997;30:1534–1. Stamm RB, Carabello BA, Mighters DL, Martin RP. Two-
dimensional echocardiographic measurement of left ventricular ejec-
tion fraction: prospective analysis of what constitutes an adequate
determination. Am Heart J 1982;104:136–44.
2. Elhendy A, Cornel JH, Roelandt JR, et al. Relation between contrac-
tile response of akinetic segments during dobutamine stress echocar-
diography and myocardial ischemia assessed by simultaneous thallium-
201 single-photon emission computed tomography. Am J Cardiol
1996;77:955–9.
3. Swann MH, Nakagawa H, Vanoli E, Lazzara R, Schwartz PJ,
Adamson PB. Heterogeneous regional endocardial repolarization is
associated with increased risk for ischemia-dependent ventricular
fibrillation after myocardial infarction. J Cardiovasc Electrophysiol
2003;14:873–9.
4. Barrabes JA, Garcia-Dorado D, Gonzalez MA, et al. Regional
expansion during myocardial ischemia predicts ventricular fibrillation
and coronary reocclusion. Am J Physiol 1998;274:H1767–75.
5. Behrens S, Li C, Franz MR. Effects of myocardial ischemia on
ventricular fibrillation inducibility and defibrillation efficacy. J Am Coll
Cardiol 1997;29:817–24.
6. Gioia G, Bagheri B, Gottlieb CD, et al. Prediction of outcome of
patients with life-threatening ventricular arrhythmias treated with
automatic implantable cardioverter-defibrillators using SPECT perfu-
sion imaging. Circulation 1997;95:390–4.
7. van der Burg AE, Bax JJ, Boersma E, Pauwels EK, van der Wall EE,
Schalij MJ. Impact of viability, ischemia, scar tissue, and revascular-
ization on outcome after aborted sudden death. Circulation. 2003;108:
1954–9.
8. Pires LA, Hull ML, Nino CL, Might LM, Ganji JR. Sudden death in
recipients of transvenous implantable cardioverter defibrillator systems:
terminal events, predictors, and potential mechanisms. J Cardiovasc41. Electrophysiol 1999;10:1049–56.
